Regional Health Properties, Inc. (RHEPA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
36/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseRHEPA / S&P 14.00% / 15.20% |
WinRHEPA / S&P 200.45% / 15.00% |
LoseRHEPA / S&P -166.53% / 50.40% |
| 2026-Q12/3 |
WinRHEPA / S&P 0.00% / -4.33% |
WinRHEPA / S&P 213.70% / 11.30% |
LoseRHEPA / S&P -153.49% / 27.70% |
| 2025-Q41/3 |
LoseRHEPA / S&P -33.33% / 2.65% |
WinRHEPA / S&P 189.91% / 9.00% |
LoseRHEPA / S&P -128.90% / 13.40% |
| 2025-Q32/3 |
WinRHEPA / S&P 172.73% / 8.12% |
WinRHEPA / S&P 121.20% / 4.61% |
LoseRHEPA / S&P -50.97% / 13.45% |
| 2025-Q22/3 |
LoseRHEPA / S&P -45.27% / 10.94% |
WinRHEPA / S&P 58.56% / 4.83% |
WinRHEPA / S&P 58.06% / 10.63% |
| 2025-Q11/3 |
LoseRHEPA / S&P -43.70% / -4.27% |
WinRHEPA / S&P 23.09% / 4.98% |
LoseRHEPA / S&P -110.00% / 10.57% |
| 2024-Q41/3 |
LoseRHEPA / S&P -30.00% / 2.41% |
WinRHEPA / S&P 6.83% / 5.25% |
LoseRHEPA / S&P -108.76% / 6.15% |
| 2024-Q30/3 |
LoseRHEPA / S&P -13.56% / 5.89% |
LoseRHEPA / S&P -24.56% / 5.89% |
LoseRHEPA / S&P -108.93% / 6.11% |
| 2024-Q20/3 |
LoseRHEPA / S&P -10.61% / 4.28% |
LoseRHEPA / S&P -42.36% / 5.38% |
LoseRHEPA / S&P -109.46% / 5.12% |
| 2024-Q11/3 |
WinRHEPA / S&P 100.00% / 10.56% |
LoseRHEPA / S&P -47.61% / 5.71% |
LoseRHEPA / S&P -358.84% / 5.59% |
| 2023-Q40/3 |
LoseRHEPA / S&P -42.11% / 11.69% |
LoseRHEPA / S&P -52.22% / 6.81% |
LoseRHEPA / S&P -321.41% / 7.78% |
| 2023-Q30/3 |
LoseRHEPA / S&P -72.33% / -3.27% |
LoseRHEPA / S&P -29.22% / 7.52% |
LoseRHEPA / S&P -315.53% / -5.03% |
| 2023-Q20/3 |
LoseRHEPA / S&P -55.31% / 8.74% |
LoseRHEPA / S&P 6.48% / 9.50% |
LoseRHEPA / S&P -309.06% / -8.57% |
| 2023-Q13/3 |
WinRHEPA / S&P 31.71% / 7.50% |
WinRHEPA / S&P 26.38% / 10.77% |
WinRHEPA / S&P 11.69% / -15.69% |
| 2022-Q43/3 |
WinRHEPA / S&P 21.53% / 7.56% |
WinRHEPA / S&P 34.60% / 11.88% |
WinRHEPA / S&P 51.96% / -17.99% |
| 2022-Q31/3 |
LoseRHEPA / S&P -39.37% / -4.88% |
WinRHEPA / S&P 34.34% / 13.47% |
LoseRHEPA / S&P RHEPA unavailable / -1.41% |
| 2022-Q22/3 |
WinRHEPA / S&P 2.15% / -16.10% |
WinRHEPA / S&P 26.50% / 13.71% |
LoseRHEPA / S&P RHEPA unavailable / 11.04% |
| 2022-Q12/3 |
WinRHEPA / S&P 1.09% / -4.60% |
WinRHEPA / S&P 30.55% / 15.97% |
LoseRHEPA / S&P RHEPA unavailable / 42.23% |
| 2021-Q41/3 |
LoseRHEPA / S&P -9.63% / 11.03% |
WinRHEPA / S&P 51.83% / 15.00% |
LoseRHEPA / S&P RHEPA unavailable / 96.40% |
| 2021-Q31/3 |
LoseRHEPA / S&P -1.17% / 0.58% |
WinRHEPA / S&P 30.07% / 10.77% |
LoseRHEPA / S&P RHEPA unavailable / 69.42% |
| 2021-Q22/3 |
WinRHEPA / S&P 92.52% / 8.55% |
WinRHEPA / S&P 19.17% / 6.58% |
LoseRHEPA / S&P RHEPA unavailable / 51.81% |
| 2021-Q12/3 |
WinRHEPA / S&P 12.87% / 6.17% |
WinRHEPA / S&P 4.43% / -1.06% |
LoseRHEPA / S&P RHEPA unavailable / 7.39% |
| 2020-Q41/3 |
WinRHEPA / S&P 21.54% / 12.15% |
LoseRHEPA / S&P -12.69% / -3.72% |
LoseRHEPA / S&P RHEPA unavailable / -33.42% |
| 2020-Q30/3 |
LoseRHEPA / S&P -1.52% / 8.93% |
LoseRHEPA / S&P -12.41% / -2.04% |
LoseRHEPA / S&P RHEPA unavailable / -27.10% |
| 2020-Q20/3 |
LoseRHEPA / S&P -0.50% / 20.54% |
LoseRHEPA / S&P -13.85% / -0.46% |
LoseRHEPA / S&P RHEPA unavailable / -27.11% |
| 2020-Q10/3 |
LoseRHEPA / S&P -51.92% / -19.60% |
LoseRHEPA / S&P -10.36% / 3.47% |
LoseRHEPA / S&P RHEPA unavailable / -14.75% |
| 2019-Q40/3 |
LoseRHEPA / S&P -17.22% / 9.07% |
LoseRHEPA / S&P -8.67% / 5.36% |
LoseRHEPA / S&P RHEPA unavailable / 2.99% |
| 2019-Q31/3 |
WinRHEPA / S&P 62.34% / 1.70% |
LoseRHEPA / S&P -8.19% / 5.02% |
LoseRHEPA / S&P RHEPA unavailable / 0.21% |
| 2019-Q20/3 |
LoseRHEPA / S&P -14.18% / 4.30% |
LoseRHEPA / S&P -10.58% / 6.64% |
LoseRHEPA / S&P RHEPA unavailable / 8.65% |
| 2019-Q11/3 |
WinRHEPA / S&P 74.22% / 13.65% |
LoseRHEPA / S&P -14.07% / 8.12% |
LoseRHEPA / S&P RHEPA unavailable / 14.29% |
| 2018-Q41/3 |
WinRHEPA / S&P 9.81% / -13.52% |
LoseRHEPA / S&P -12.33% / 9.05% |
LoseRHEPA / S&P RHEPA unavailable / 18.23% |
| 2018-Q30/3 |
LoseRHEPA / S&P -30.36% / 7.71% |
LoseRHEPA / S&P -8.22% / 10.21% |
LoseRHEPA / S&P RHEPA unavailable / 19.06% |
| 2018-Q20/3 |
LoseRHEPA / S&P -66.74% / 3.43% |
LoseRHEPA / S&P -6.92% / 9.03% |
LoseRHEPA / S&P RHEPA unavailable / 14.46% |
| 2018-Q11/3 |
WinRHEPA / S&P 1.25% / -0.76% |
LoseRHEPA / S&P -6.21% / 7.68% |
LoseRHEPA / S&P RHEPA unavailable / 12.46% |
| 2017-Q40/3 |
LoseRHEPA / S&P RHEPA unavailable / 6.64% |
LoseRHEPA / S&P -8.89% / 7.03% |
LoseRHEPA / S&P RHEPA unavailable / 13.82% |
| 2017-Q30/3 |
LoseRHEPA / S&P RHEPA unavailable / 4.48% |
LoseRHEPA / S&P -9.72% / 5.68% |
LoseRHEPA / S&P RHEPA unavailable / 17.57% |
| 2017-Q20/3 |
LoseRHEPA / S&P RHEPA unavailable / 3.09% |
LoseRHEPA / S&P -3.13% / 4.83% |
LoseRHEPA / S&P RHEPA unavailable / 17.74% |
| 2017-Q11/3 |
LoseRHEPA / S&P RHEPA unavailable / 6.07% |
WinRHEPA / S&P 11.41% / 3.67% |
LoseRHEPA / S&P RHEPA unavailable / 13.32% |
| 2016-Q41/3 |
LoseRHEPA / S&P RHEPA unavailable / 3.82% |
WinRHEPA / S&P 50.01% / 2.09% |
LoseRHEPA / S&P RHEPA unavailable / 7.05% |
| 2016-Q31/3 |
LoseRHEPA / S&P RHEPA unavailable / 3.85% |
WinRHEPA / S&P 3673.81% / 0.20% |
LoseRHEPA / S&P RHEPA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | RHEPA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -19.87% | 20.78% |
| Annualized return | -19.87% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | RHEPA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -95.45% | 83.14% |
| Annualized return | -46.10% | 12.86% |
10Y · 2017-10-24 to 2026-08-27
| Metric | RHEPA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -98.49% | 319.30% |
| Annualized return | -34.24% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.